StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research report report published on Sunday morning. The brokerage issued a sell rating on the basic materials company’s stock.
Separately, HC Wainwright reiterated a buy rating and issued a $10.00 price target on shares of Arcadia Biosciences in a research report on Friday, April 5th.
View Our Latest Report on RKDA
Arcadia Biosciences Stock Up 1.5 %
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last issued its earnings results on Thursday, March 28th. The basic materials company reported ($2.48) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($2.68) by $0.20. Arcadia Biosciences had a negative return on equity of 81.56% and a negative net margin of 246.80%. The business had revenue of $1.17 million during the quarter, compared to analysts’ expectations of $1.80 million. On average, equities research analysts expect that Arcadia Biosciences will post -5.01 EPS for the current year.
About Arcadia Biosciences
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Further Reading
- Five stocks we like better than Arcadia Biosciences
- How Can Investors Benefit From After-Hours Trading
- High-Yield Texas Instruments Could Hit New Highs Soon
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.